These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 8866691)

  • 21. Evidence for increased dorsal hippocampal adenosine release and metabolism during pharmacologically induced seizures in rats.
    Berman RF; Fredholm BB; Aden U; O'Connor WT
    Brain Res; 2000 Jul; 872(1-2):44-53. PubMed ID: 10924674
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Kynurenic acid, by targeting α7 nicotinic acetylcholine receptors, modulates extracellular GABA levels in the rat striatum in vivo.
    Beggiato S; Antonelli T; Tomasini MC; Tanganelli S; Fuxe K; Schwarcz R; Ferraro L
    Eur J Neurosci; 2013 May; 37(9):1470-7. PubMed ID: 23442092
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Systemic d-amphetamine administration causes a reduction of kynurenic acid levels in rat brain.
    Rassoulpour A; Wu HQ; Poeggeler B; Schwarcz R
    Brain Res; 1998 Aug; 802(1-2):111-8. PubMed ID: 9748528
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Fluctuations in endogenous kynurenic acid control hippocampal glutamate and memory.
    Pocivavsek A; Wu HQ; Potter MC; Elmer GI; Pellicciari R; Schwarcz R
    Neuropsychopharmacology; 2011 Oct; 36(11):2357-67. PubMed ID: 21796108
    [TBL] [Abstract][Full Text] [Related]  

  • 25. L-4-chlorokynurenine attenuates kainate-induced seizures and lesions in the rat.
    Wu HQ; Lee SC; Scharfman HE; Schwarcz R
    Exp Neurol; 2002 Sep; 177(1):222-32. PubMed ID: 12429224
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Long-term systemic administration of kynurenic acid brain region specifically elevates the abundance of functional CB
    Zádor F; Nagy-Grócz G; Dvorácskó S; Bohár Z; Cseh EK; Zádori D; Párdutz Á; Szűcs E; Tömböly C; Borsodi A; Benyhe S; Vécsei L
    Neurochem Int; 2020 Sep; 138():104752. PubMed ID: 32445659
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Cortical kynurenic acid bi-directionally modulates prefrontal glutamate levels as assessed by microdialysis and rapid electrochemistry.
    Konradsson-Geuken A; Wu HQ; Gash CR; Alexander KS; Campbell A; Sozeri Y; Pellicciari R; Schwarcz R; Bruno JP
    Neuroscience; 2010 Sep; 169(4):1848-59. PubMed ID: 20600676
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Systemic administration of kainate induces marked increases of endogenous kynurenic acid in various brain regions and plasma of rats.
    Baran H; Gramer M; Hönack D; Löscher W
    Eur J Pharmacol; 1995 Nov; 286(2):167-75. PubMed ID: 8605953
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Specific inhibition of kynurenate synthesis enhances extracellular dopamine levels in the rodent striatum.
    Amori L; Wu HQ; Marinozzi M; Pellicciari R; Guidetti P; Schwarcz R
    Neuroscience; 2009 Mar; 159(1):196-203. PubMed ID: 19138730
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Quantitative differences in the effects of de novo produced and exogenous kynurenic acid in rat brain slices.
    Scharfman HE; Hodgkins PS; Lee SC; Schwarcz R
    Neurosci Lett; 1999 Oct; 274(2):111-4. PubMed ID: 10553950
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Stress-induced impairment in fear discrimination is causally related to increased kynurenic acid formation in the prefrontal cortex.
    Klausing AD; Fukuwatari T; Bucci DJ; Schwarcz R
    Psychopharmacology (Berl); 2020 Jul; 237(7):1931-1941. PubMed ID: 32215686
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Dual effect of DL-homocysteine and S-adenosylhomocysteine on brain synthesis of the glutamate receptor antagonist, kynurenic acid.
    Luchowska E; Luchowski P; Paczek R; Ziembowicz A; Kocki T; Turski WA; Wielosz M; Lazarewicz J; Urbanska EM
    J Neurosci Res; 2005 Feb; 79(3):375-82. PubMed ID: 15605380
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Elevated levels of kynurenic acid change the dopaminergic response to amphetamine: implications for schizophrenia.
    Olsson SK; Andersson AS; Linderholm KR; Holtze M; Nilsson-Todd LK; Schwieler L; Olsson E; Larsson K; Engberg G; Erhardt S
    Int J Neuropsychopharmacol; 2009 May; 12(4):501-12. PubMed ID: 18796185
    [TBL] [Abstract][Full Text] [Related]  

  • 34. In situ produced 7-chlorokynurenate provides protection against quinolinate- and malonate-induced neurotoxicity in the rat striatum.
    Guidetti P; Wu HQ; Schwarcz R
    Exp Neurol; 2000 May; 163(1):123-30. PubMed ID: 10785450
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Electrophysiological effects of exogenous and endogenous kynurenic acid in the rat brain: studies in vivo and in vitro.
    Scharfman HE; Goodman JH; Schwarcz R
    Amino Acids; 2000; 19(1):283-97. PubMed ID: 11026500
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Enzyme-catalyzed production of the neuroprotective NMDA receptor antagonist 7-chlorokynurenic acid in the rat brain in vivo.
    Wu HQ; Salituro FG; Schwarcz R
    Eur J Pharmacol; 1997 Jan; 319(1):13-20. PubMed ID: 9030892
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Kynurenic acid: a new effector of valproate action?
    Maciejak P; Szyndler J; Turzyńska D; Sobolewska A; Płaźnik A
    Pharmacol Rep; 2011; 63(6):1569-73. PubMed ID: 22358107
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Increased phasic activity of dopaminergic neurones in the rat ventral tegmental area following pharmacologically elevated levels of endogenous kynurenic acid.
    Erhardt S; Engberg G
    Acta Physiol Scand; 2002 May; 175(1):45-53. PubMed ID: 11982504
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The effects of electrical hippocampal kindling of seizures on amino acids and kynurenic acid concentrations in brain structures.
    Szyndler J; Maciejak P; Turzyńska D; Sobolewska A; Walkowiak J; Płaźnik A
    J Neural Transm (Vienna); 2012 Feb; 119(2):141-9. PubMed ID: 21861191
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Losartan Reverses Hippocampal Increase of Kynurenic Acid in Type 1 Diabetic Rats: A Novel Procognitive Aspect of Sartan Action.
    Chmiel-Perzyńska I; Perzyński A; Olajossy B; Gil-Kulik P; Kocki J; Urbańska EM
    J Diabetes Res; 2019; 2019():4957879. PubMed ID: 31737685
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.